Sangamo BioSciences

                   

BUYINS.NET: Market Maker Surveillance Report. Top 6 Gainers With Lowest Price Friction For...

tmcnet.com
13-Nov-2008 6 related
        

BUYINS.NET, www.buyins.net, announced today a list of the top 6 companies with the highest percentage intraday gain and least Market Maker Price Friction (positive) in their stock prices. Market Maker Friction Factor is shown...

add comment
                   

Brief afternoon bounce rebuffed on profit worries, commodities slump (SmallCapInvestor.com)

yahoo.com
11-Nov-2008 1 related
        

Tuesday November 11, 4:25 pm ET Small-cap stocks took a dive again Tuesday, rejecting a brief afternoon bounce into positive territory as concerns about the economy, tumbling corporate profits and slumping commodity markets...

add comment
                   

Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601

medicalnewstoday.com
11-Nov-2008 21 related
        

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced top-line data from its SB-509-601 clinical trial, one of Sangamo's three Phase 2 clinical studies from its ZFP Therapeutic(TM) program to develop SB-509 for diabetic neuropathy...

add comment
                   

Unusual 11 Mid-Day Movers 11/11: OPTR, TMA, HQS, HZO Higher; GGP, DSL, SGMO, GNW Lower

streetinsider.com
11-Nov-2008 2 related
        

Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) 87.6% HIGHER; released positive top-line results from a pivotal Phase 3 clinical study of the Company's lead anti-infective drug candidate, OPT-80, in patients with Clostridium...

add comment
                   

Movers: American Express, Starbucks, Alcoa, Citigroup

businessweek.com
11-Nov-2008 2 related
        

Stocks in the news on Tuesday American Express announces that the U.S. Federal Reserve has approved its application to become licensed as a bank holding company and to be regulated by the Federal Reserve. Starbucks posts $0.10,...

add comment
                   

Small caps extend Monday’s slide (SmallCapInvestor.com)

yahoo.com
11-Nov-2008 2 related
        

Tuesday November 11, 10:10 am ET Small-cap stocks tumbled on the open, pulled down by spillover selling from a decline in overseas markets fueled by a weak tone in financial and commodity shares. This morning’s soft tone on...

add comment
                   

Sangamo BioSciences Reports Third Quarter 2008 Financial Results

finanznachrichten.de
29-Oct-2008 2 related
        

RICHMOND, Calif., Oct. 29 /PRNewswire-FirstCall/ -- The increase in research and development expenses for the third quarter of 2008 was primarily due to advancing the company's clinical development programs in diabetic...

add comment

Earnings roundup: Prudential, MetLife

ibtimes.com
29-Oct-2008 7 related
        

Among the earnings stories for Wednesday, Oct. 29, from AP Financial News: NEWARK, N.J. (AP)--Insurance and investment company Prudential Financial says unfavorable market conditions drove it to report a third-quarter loss,...

add comment
                   

Sangamo has wider 3rd-qtr loss on nerve drug costs

ibtimes.com
29-Oct-2008 1 related
        

Sangamo BioSciences Inc. said Wednesday its loss widened in the third quarter as it spent more money to develop its nerve drug candidate SB-509. Sangamo reported a net loss of $6.3 million, or 15 cents per share, in the most...

add comment
                   

Sangamo BioSciences reports wider loss after increasing spending on nerve drug candidate

canadianbusiness.com
29-Oct-2008
        

RICHMOND, Calif. (AP) - Sangamo BioSciences Inc. said Wednesday its loss widened in the third quarter as it spent more money to develop its nerve drug candidate SB-509. Sangamo reported a net loss of $6.3 million, or 15 cents...

add comment
1 2 next